Emmanuel Broussolle Selected Research

Levodopa (L Dopa)

10/2020	Characterization of Recessive Parkinson Disease in a Large Multicenter Study.
1/2019	Wait and you shall see: sexual delay discounting in hypersexual Parkinson's disease.
1/2016	A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced Dyskinesia.
9/2015	Behavioural impact of a double dopaminergic and serotonergic lesion in the non-human primate.
6/2015	Dopa-Responsive Dystonia and gait analysis: A case study of levodopa therapeutic effects.
2/2013	C9orf72 repeat expansions are a rare genetic cause of parkinsonism.
1/2013	Psychostimulant effect of levodopa: reversing sensitisation is possible.
2/2009	Bilateral subthalamic nucleus stimulation in advanced Parkinson's disease: five year follow-up.
8/2003	How much phenotypic variation can be attributed to parkin genotype?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emmanuel Broussolle Research Topics

Disease

22	Parkinson Disease (Parkinson's Disease) 12/2021 - 05/2003
5	Dystonia (Limb Dystonia) 06/2015 - 08/2003
4	Dyskinesias (Dyskinesia) 01/2016 - 08/2004
3	Dementia (Dementias) 10/2020 - 02/2013
3	Hepatolenticular Degeneration (Wilson's Disease) 01/2020 - 01/2017
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 08/2018 - 02/2013
3	Disease Progression 01/2014 - 11/2004
2	Dopa-responsive Dystonia 01/2019 - 06/2015
2	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 08/2018
2	Tardive Dyskinesia 08/2014 - 06/2008
2	Dystonic Disorders (Writer's Cramp) 01/2014 - 08/2009
2	Huntington Disease (Huntington's Disease) 01/2014 - 01/2009
2	Movement Disorders (Movement Disorder) 01/2014 - 11/2009
1	Autonomic Nervous System Diseases (Dysautonomia) 10/2020
1	End Stage Liver Disease 01/2020
1	Pathologic Processes 01/2019
1	Essential Tremor (Essential Tremors) 01/2019
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2019
1	Multiple System Atrophy 01/2019
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2018
1	Tourette Syndrome (Tourette's Syndrome) 01/2018
1	Mental Disorders (Mental Disorder) 01/2017
1	Cognitive Dysfunction 04/2016
1	Nausea 01/2016
1	Fatigue 01/2016
1	Shock 01/2014
1	Anhedonia 05/2013
1	Parkinsonian Disorders (Parkinsonism) 02/2013
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 05/2012
1	Mania (Manias) 06/2011
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 01/2010
1	Cerebral Palsy (Spastic Diplegia) 08/2009
1	Infections 02/2009
1	Carcinoma (Carcinomatosis) 02/2009
1	Weight Loss (Weight Reduction) 01/2009
1	Tremor (Tremors) 08/2005
1	Myoclonus (Nocturnal Myoclonus) 12/2003
1	Kidney Neoplasms (Kidney Cancer) 12/2003
1	Abnormal Reflex (Hyperreflexia) 08/2003

Drug/Important Bio-Agent (IBA)

9	Levodopa (L Dopa)FDA LinkGeneric 10/2020 - 08/2003
5	Dopamine (Intropin)FDA LinkGeneric 12/2021 - 04/2010
3	Pharmaceutical PreparationsIBA 12/2021 - 11/2004
3	CopperIBA 01/2020 - 01/2017
3	Antipsychotic Agents (Antipsychotics)IBA 01/2019 - 06/2008
2	Serotonin (5 Hydroxytryptamine)IBA 12/2021 - 09/2015
1	benzylamineIBA 12/2021
1	Technetium Tc 99m Exametazime (Ceretec)FDA Link 01/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2019
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2019
1	Dihydroxyphenylalanine (Dopa)IBA 01/2019
1	ioflupaneIBA 01/2019
1	IsotopesIBA 08/2018
1	ZincIBA 08/2018
1	Clonidine (ST 155)FDA LinkGeneric 01/2018
1	Biological ProductsIBA 01/2017
1	Ceruloplasmin (Ferroxidase)IBA 01/2017
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2016
1	3- (6- p- tolylpyridin- 3- yloxy)- 1- azabicyclo(2.2.2)octaneIBA 01/2016
1	Therapeutic UsesIBA 06/2015
1	Dopamine Agonists (Dopamine Agonist)IBA 05/2013
1	Piribedil (Trivastal)IBA 05/2013
1	Dopamine Agents (Dopaminergic Agents)IBA 05/2012
1	5-HT1A Serotonin ReceptorIBA 01/2012
1	Alanine-tRNA LigaseIBA 01/2010
1	Ala Transfer RNAIBA 01/2010
1	Hormones (Hormone)IBA 01/2009
1	Leucine (L-Leucine)FDA Link 03/2007
1	Phosphotransferases (Kinase)IBA 03/2007
1	Dopamine Receptors (Dopamine Receptor)IBA 11/2004
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 11/2004
1	adrafinil (Olmifon)IBA 08/2004
1	Modafinil (Provigil)FDA Link 08/2004
1	Interferon-alpha (Interferon Alfa)IBA 12/2003
1	fluorodopa F 18IBA 05/2003

Therapy/Procedure

9	Deep Brain Stimulation 01/2018 - 08/2004
8	Therapeutics 01/2020 - 12/2003
2	Denervation 12/2021 - 04/2010
2	Liver Transplantation 01/2020 - 01/2017
2	Operative Surgical Procedures 08/2009 - 08/2005
1	Electrodes (Electrode) 01/2014
1	Transcranial Magnetic Stimulation 01/2014
1	Noninvasive Ventilation 09/2013
1	Device Removal (Removal, Device) 02/2009